The phrase "analogue formulation" is correct and usable in written English.
It can be used in contexts related to discussions about methods, processes, or models that are based on analog systems or concepts.
Example: "The research paper presents an analogue formulation of the problem, allowing for a more intuitive understanding of the underlying dynamics."
Alternatives: "analog model" or "analog representation".
The failure of the 3-month GnRH analogue formulation in achieving ovarian function suppression has been previously reported either in breast and in prostate cancer patients (Yri et al, 2006; Schmid et al, 2007).
The study subjects were randomly assigned to twice-daily insulin therapy with BIAsp70/30 (NovoRapid 30 Mix®), a biphasic insulin analogue formulation given twice daily immediately before breakfast and dinner (30 Mix group), or to basal-bolus insulin therapy with insulin aspart (NovoRapid®) in combination with NPH insulin injected at night on an on-demand basis (BB group).
Subjects comprised type 2 diabetic patients aged 20-79 years, treated with twice daily premixed insulin or insulin analogue formulations.
To evaluate glycemic variability associated with two different premixed insulin analogue formulations when used in a twice-daily regimen.
To the best of our knowledge, there are only two studies reported in the literature comparing premixed insulin analogue formulations and premixed insulin formulations.
However there have been no reports comparing the effect of these premixed insulin analogue formulations on glycemic variability when used in a twice-daily regimen.
Study subjects comprised type 2 diabetic patients aged between 20 and less than 80 years old, who were treated with premixed insulin preparations or premixed insulin analogue formulations, twice daily.
While there is general agreement that the currently available basal insulin analogue formulations are superior to human NPH insulin, in particular with respect to the risk of hypoglycaemia [ 17], there is no consensus as to which of the two available basal analogues should be recommended to initiate insulin treatment and what the potential differences are, if any, in patients with T2DM.
While most studies support the notion that currently available analogue formulations of both basal and premixed insulin are superior to their human insulin counterparts with respect to the risk of hypoglycaemia (16, 17), there is a lack of a uniform consensus as to which of the two regimens should be recommended to initiate insulin treatment in patients with T2D.
New insulin analogues and formulations are being developed with pharmacokinetic properties to speed-up or prolong transfer from a subcutaneous injection site to the target tissues, or to selectively favour effects on the liver.
There are multiple pharmacological analogues and formulations of vitamin D available for clinical use [ 22, 23].
